Hysterometers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Disposable, Reusable), By End User (Gynecology Clinics, Hospitals, Others), By Region, By Competition Forecast & Opportunities 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 775.27 Million
CAGR (2026-2031)	6.23%
Fastest Growing Segment	Reusable
Largest Market	North America
Market Size (2031)	USD 1114.13 Million

Market Overview

The Global Hysterometers Market will grow from USD 775.27 Million in 2025 to USD 1114.13 Million by 2031 at a 6.23% CAGR. A hysterometer is a gynecological instrument designed to measure the depth and positioning of the uterine cavity, serving as an essential tool for procedures such as intrauterine device insertion and diagnostic assessments. The Global Hysterometers Market is primarily driven by the escalating burden of gynecological diseases and the expanding utilization of long-acting reversible contraception. Furthermore, the rising demand for assisted reproductive technologies supports the fundamental necessity for accurate uterine assessment. According to the 'American Cancer Society', in '2024', approximately '67,880' new cases of uterine corpus cancer were projected to be diagnosed in the United States, illustrating the growing clinical requirement for such diagnostic devices.

However, the market encounters a substantial challenge related to the risk of iatrogenic injuries, such as uterine perforation and infection. These procedural complications can deter clinical usage and necessitate extensive provider training, thereby restricting market reach in regions with limited skilled personnel. Additionally, stringent regulatory compliance for medical devices hampers the rapid commercialization of innovative product variations, further impeding expansion in cost-sensitive markets.

Key Market Drivers

The rising prevalence of uterine fibroids and other gynecological disorders is a primary catalyst propelling the global hysterometers market. As these benign tumors and structural anomalies often distort the uterine cavity, accurate measurement of uterine depth and cavity direction becomes clinically imperative prior to surgical interventions or the insertion of intrauterine devices. Hysterometers are essential for preventing iatrogenic injuries, such as uterine perforation, during these diagnostic and therapeutic procedures, thereby ensuring patient safety and procedural efficacy. The increasing burden of these conditions directly correlates with higher procedural volumes, sustaining the demand for precise measurement instruments. According to the National Institutes of Health (NIH), in February 2024, a comprehensive global study reported that the incidence of uterine fibroids has continued to rise, with approximately 9.6 million new cases diagnosed annually during the most recent assessment period. This escalating disease burden necessitates frequent gynecological examinations, fundamentally anchoring the market's growth trajectory.

Furthermore, the substantial growth in assisted reproductive technologies (ART) and fertility treatments has intensified the clinical reliance on hysterometers. In in-vitro fertilization (IVF) protocols, sounding the uterus to determine the exact length and axial direction of the cervical canal is a critical step to ensure the atraumatic placement of embryos. Precise placement is vital for optimizing implantation rates and minimizing the risk of ectopic pregnancies or expulsion, creating a robust recurring demand for both reusable and disposable sounding devices. According to the Society for Assisted Reproductive Technology (SART), in 2024, it was reported that a record 415,953 ART cycles were performed in the United States during the previous year, reflecting a surge in fertility care utilization. Underscoring the commercial expansion of this sector, The Cooper Companies, Inc. reported in December 2024 that its fertility and women’s healthcare business segment achieved net sales of approximately $1.29 billion for the fiscal year.

Download Free Sample Report

Key Market Challenges

The risk of iatrogenic injuries, particularly uterine perforation and infection, acts as a significant restraint on the growth of the Global Hysterometers Market. Because these instruments are invasive and require precise manipulation to measure uterine depth, the potential for causing physical trauma deters their widespread adoption, especially in non-hospital settings. This safety concern forces healthcare systems to restrict the use of hysterometers to specialized facilities with immediate surgical backup, thereby preventing the device from becoming a standard tool in primary care or resource-limited clinics. Consequently, the market struggles to expand in regions where there is a scarcity of highly skilled gynecologists capable of mitigating these procedural risks.

The necessity for extensive provider training to prevent such complications further hampers market scalability. The fear of adverse outcomes creates a high barrier to entry for less experienced practitioners, slowing the clinical uptake of these devices. According to the 'European Society for Gynaecological Endoscopy', in '2024', the complication rate for outpatient hysteroscopy was reported at approximately '0.8%', with procedural failure occurring in roughly '3.2%' of cases due to technical difficulties or patient discomfort. Although these statistical figures may seem minor, they translate to a substantial number of adverse events globally, reinforcing the strict operational requirements that limit the rapid commercialization and mass utilization of hysterometers.

Key Market Trends

The widespread transition to single-use disposable instruments is reshaping the global hysterometers market, driven by the critical need to eliminate cross-contamination risks and streamline clinical workflows. Healthcare facilities are increasingly favoring sterile, one-time-use uterine sounds over reusable metal variants to negate the costs and logistical burdens associated with sterilization, particularly in high-volume fertility clinics where atraumatic precision is required. This shift towards disposable consumables is evident in the financial performance of major industry players catering to reproductive health. According to The Cooper Companies, Inc., December 2024, in the 'Fourth Quarter and Full Year 2024 Results', the fertility segment reported a revenue increase of 15%, significantly driven by the robust sales of consumables used in reproductive procedures.

Concurrently, the migration of gynecological procedures to ambulatory and office-based settings is fueling the demand for compact, efficient diagnostic tools like hysterometers. Healthcare systems are prioritizing outpatient care models to reduce operational costs and improve patient comfort, leading to a surge in the utilization of handheld instruments that facilitate immediate diagnostic assessments outside the traditional operating room. This trend is supported by the growing commercial success of surgical and diagnostic divisions focused on minimally invasive women's health solutions. According to Hologic, Inc., November 2024, in the 'Financial Results for Fourth Quarter of Fiscal 2024', surgical revenue grew by 5.7%, underscoring the expanding global adoption of gynecological devices designed for minimally invasive and outpatient care.

Segmental Insights

The Reusable segment is recognized as the fastest-growing category in the Global Hysterometers Market, primarily driven by the increasing demand for cost-effective and sustainable medical solutions. Healthcare facilities are increasingly adopting reusable stainless steel instruments to minimize the recurring procurement expenses and logistical burdens associated with single-use devices. This preference is further reinforced by global initiatives aiming to reduce hazardous medical waste. Compliance with rigorous sterilization protocols, such as those outlined by the Centers for Disease Control and Prevention, ensures these instruments maintain high safety standards for repeated clinical application.

Regional Insights

North America currently leads the Global Hysterometers Market, driven by the high prevalence of gynecological disorders such as uterine fibroids and pelvic organ prolapse. This dominance is supported by a well-established healthcare infrastructure and the presence of major medical device manufacturers within the region. Furthermore, healthcare professionals here demonstrate a strong preference for minimally invasive diagnostic procedures. The market also benefits from a robust regulatory framework, where consistent approvals from the U.S. Food and Drug Administration (FDA) facilitate the availability of compliant devices, collectively securing North America’s position as the primary revenue generator.

Recent Developments

• In October 2025, Aspivix, a medical technology company focused on women's health, officially launched its Carevix device in the United States. Carevix is a novel, suction-based cervical stabilizer designed as a modern alternative to the traditional tenaculum, which is often used during intrauterine procedures such as IUD insertion and hysterometry. The device's launch followed its successful clinical validation and regulatory clearances, offering a less painful and less traumatic experience for patients undergoing uterine measurements and interventions. This development represents a significant advancement in the tools used alongside hysterometers for routine gynecological exams.
• In October 2024, Hologic, Inc., a major player in the women's health medical technology sector, announced a definitive agreement to acquire Gynesonics, the developer of the Sonata System, for USD 350 million. The Sonata System is a transcervical, intrauterine fibroid treatment device that combines ultrasound guidance with radiofrequency energy. While Hologic is a key competitor in the broader gynecological instrument space, this acquisition significantly strengthened its minimally invasive surgical lineup. The transaction provided Hologic with an innovative, incision-free solution for uterine conditions, aligning with the market's growing demand for uterus-preserving technologies.
• In August 2024, CooperSurgical, a prominent leader in the women’s healthcare and hysterometers market, completed the acquisition of obp Surgical for approximately USD 100 million. The acquisition integrated obp Surgical’s suite of single-use cordless surgical retractors and suction devices into CooperSurgical’s extensive medical device portfolio. This strategic move was designed to enhance CooperSurgical’s offerings for obstetric and gynecological procedures, complementing their existing range of intrauterine and surgical tools. The deal underscores the industry's shift towards disposable, self-illuminated devices that improve visualization and workflow for clinicians.
• In February 2024, Innovia Medical announced the availability of the DTR Medical Cervical Rotating Biopsy Punch in the United States market. This single-use gynecological instrument, designed to obtain high-quality cervical biopsies, had previously been successful in the United Kingdom. DTR Medical is a recognized manufacturer in the global market for gynecological instruments, including single-use hysterometers. The expansion into the U.S. demonstrates the company's strategy to broaden the reach of its disposable instrument portfolio, which aims to improve clinical efficiency and patient safety by reducing cross-contamination risks associated with reusable devices.

Key Market Players

• CooperSurgical, Inc.
• MedGyn Products, Inc.
• SMB Corporation of India
• Surtex Instruments Ltd.
• RI.MOS. S.R.L
• Pregna International Ltd.
• Pelican Feminine Healthcare Ltd.
• Sterylab S.r.l
• Bexen Medical
• Wallach Surgical Devices

By Type	By End User	By Region
Disposable Reusable	Gynecology Clinics Hospitals Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Hysterometers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Hysterometers Market, By Type:

• Disposable
• Reusable

• Hysterometers Market, By End User:

• Gynecology Clinics
• Hospitals
• Others

• Hysterometers Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE